中國醫療網絡(00383.HK):上交所對公司董事周立業及周海英處以公開譴責
格隆匯5月11日丨中國醫療網絡(00383.HK)發佈公告,公司近期獲公司非執行董事及主席周立業先生以及公司執行董事周海英先生(周先生)知會,彼等接獲上海證券交易所發出關於對同方股份(600100.SH)的紀律處分決定書202035號。於相關時間,周主席擔任同方董事會主席及周先生擔任同方財務總監。
於該決定內,上交所提述同方於2019年1月31日發佈的2018年年度業績預虧公告,內容有關同方就2018年財政年度將取得預期虧損;同方於2019年4月25日刊發的業績預告更正公告,當中澄清2018年財政年度的預期虧損將大幅增加;及同方於2019年4月26日刊發的2018年年度報告,內容有關2018年財政年度的實際虧損。
上交所亦提述同方的預虧公告內披露的預期虧損與年報披露的實際虧損之間存在重大差異。鑑於該等重大差異,上交所認為同方因於預虧公告內披露不準確資料已違反根據上交所股票上市規則。上交所亦認為,同方並未於預虧公告內發出有關事項的充分及具體風險預警,從而可能導致該預虧公告不準確,並且未能及時發佈更正公告更正預期虧損數字。
上交所進一步認為,同方於相關時間負責與預虧公告有關資料披露的有關人員亦須負責,且已違反上交所上市規則。因此,上交所對周主席(於相關時間擔任同方董事會主席)及周先生(於相關時間擔任同方財務總監)處以公開譴責。
此外,公司董事會已評估該決定,並認為周主席及周先生仍適合擔任董事。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.